Literature DB >> 12651226

Interleukin-17 family and IL-17 receptors.

T A Moseley1, D R Haudenschild, L Rose, A H Reddi.   

Abstract

Interleukin-17 (IL-17) is a pro-inflammatory cytokine secreted by activated T-cells. Recently discovered related molecules are forming a family of cytokines, the IL-17 family. The prototype member of the family has been designated IL-17A. Due to recent advances in the human genome sequencing and proteomics five additional members have been identified and cloned: IL-17B, IL-17C, IL-17D, IL-17E and IL-17F. The cognate receptors for the IL-17 family identified thus far are: IL-17R, IL-17RH1, IL-17RL (receptor like), IL-17RD and IL-17RE. However, the ligand specificities of many of these receptors have not been established. The IL-17 signaling system is operative in disparate tissues such as articular cartilage, bone, meniscus, brain, hematopoietic tissue, kidney, lung, skin and intestine. Thus, the evolving IL-17 family of ligands and receptors may play an important role in the homeostasis of tissues in health and disease beyond the immune system. This survey reviews the biological actions of IL-17 signaling in cancers, musculoskeletal tissues, the immune system and other tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651226     DOI: 10.1016/s1359-6101(03)00002-9

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  288 in total

1.  Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice.

Authors:  Ivana De Domenico; Tian Y Zhang; Curry L Koening; Ryan W Branch; Nyall London; Eric Lo; Raymond A Daynes; James P Kushner; Dean Li; Diane M Ward; Jerry Kaplan
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.

Authors:  Lubin Qiu; Dongsheng He; Xiang Fan; Zhi Li; Chuangxin Liao; Yonghong Zhu; Haijun Wang
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

3.  Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.

Authors:  Xuesong Qian; Huan Ning; Jidong Zhang; Daniel F Hoft; Deborah J Stumpo; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 4.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 5.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

6.  Distinct regulation of interleukin-17 in human T helper lymphocytes.

Authors:  Zhi Chen; Cristina M Tato; Linda Muul; Arian Laurence; John J O'Shea
Journal:  Arthritis Rheum       Date:  2007-09

Review 7.  IL-17F: regulation, signaling and function in inflammation.

Authors:  Seon Hee Chang; Chen Dong
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

8.  Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.

Authors:  Haseeb Ilias Basha; Sabarinathan Ramachandran; Venkataswarup Tiriveedhi; Masashi Takenaka; Vijay Subramanian; Dilip S Nath; Nicholas Benshoff; G Alec Patterson; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

9.  IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling.

Authors:  Zhili Rong; Anan Wang; Zhiyong Li; Yongming Ren; Long Cheng; Yinghua Li; Yinyin Wang; Fangli Ren; Xiaoning Zhang; Jim Hu; Zhijie Chang
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

10.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

Authors:  Stefan Haak; Andrew L Croxford; Katharina Kreymborg; Frank L Heppner; Sandrine Pouly; Burkhard Becher; Ari Waisman
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.